Patent details

Basic Information

Publication number:

EP2153819

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP091760496

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of a solubility enhancing component in an aqueous composition comprising brimonidine tartrate

French Title of Invention:

Utilisation d'un agent augmentant la solubilité dans une composition aqueuse comprenant tartrate de brimonidine

German Title of Invention:

Verwendung von einem Löslichkeitsvermittler in einer wässerigen Zusammensetzung enthaltend Brimonidintartrat

SPC Number:

Dates

Filing date:

09/07/2001

Grant date:

05/09/2012

EP Publication Date:

05/09/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/02/2010

EP B1 Publication Date:

05/09/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/07/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/07/2001

 

 

Name:

Allergan Inc.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

24/10/2012

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Olejnik Orest

Address:

United States (US)

2

Name:

Kerslake Edward D. S.

Address:

United States (US)

Priority

Priority Number:

218206

Priority Date:

14/07/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/08;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/07/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages